Immunogenicity Assessment of Lipegfilgrastim in Patients with Breast Cancer Receiving Chemotherapy

Lipegfilgrastim is a long-acting, once-per-cycle, glycopegylated recombinant granulocyte colony-stimulating factor (G-CSF) used to prevent neutropenia in patients receiving myelosuppressive chemotherapy. This integrated analysis examined the immunogenicity of lipegfilgrastim and its potential clinic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunol Res
Hlavní autoři: Zou, Linglong, Buchner, Anton, Roberge, Martin, Liu, Patrick M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4935921/
https://ncbi.nlm.nih.gov/pubmed/27419145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9248061
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky